Identification of a Biomarker Combination for Survival Stratification in pStage II/III Gastric Cancer after Curative Resection.

Itaru HashimotoYayoi KimuraNaohide OueYukihiko HiroshimaToru AoyamaYasushi RinoTomoyuki YokoseWataru YasuiYohei MiyagiTakashi Oshima

Published in: Cancers (2022)

A combination of four proteins in GC tissues may serve as useful survival risk stratification markers in patients with pStage II/III GC following curative resection. Our results may facilitate future multicenter prospective clinical trials.

Keyphrases

clinical trial
rectal cancer
free survival
prognostic factors
gene expression
gas chromatography
randomized controlled trial
current status
cross sectional
high resolution
double blind
phase ii
phase iii